Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-09

Clinical Trial Update: Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes [Phase 2]

View source ↗

Summary

This update reports on a Phase 2 trial comparing weekly LAPS-Exendin versus placebo for glycemic control in adults with Type 2 diabetes; the study status is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LAPS-Exendin

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED